Market Trends Stoke Therapeutics GAAP EPS of -$0.18 beats by $0.35, revenue of $22.6M beats by $18.33MBy admin8996erT0allMarch 19, 2025 Stoke Therapeutics press release (NASDAQ:STOK): Q4 GAAP EPS of -$0.18 beats by $0.35. Revenue of $22.61M (+707.1% Y/Y) beats by…
